[March 11, 2013]

Research and Markets: PharmaPoint Report: Epilepsy - Current and Future Players Analysis Featuring UCB, Eisai, Pfizer, GSK, Novartis, Abbott and DSP

Research and Markets (http://www.researchandmarkets.com/research/q6mpk2/pharmapoint) has announced the addition of GlobalData's new report "PharmaPoint: Epilepsy - Current and Future Players" to their offering.

PharmaPoint: Epilepsy - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Epilepsy Market. The report identifies and analyses the key companies shaping and driving the global Epilepsy market. The report provides insight into the competitive Epilepsy landscape, including new companies entering the market.

Scope

- Investigation of current and future market competition fo Epilepsy

- Competitor assessment

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of the Epilepsy sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Epilepsy Market

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

- What's the next big thing in the global Epilepsy market landscape Identify, understand and capitalize

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Outlook

4 Current and Future Players

4.1 Overview

4.2 Trends in Corporate Strategy

4.3 Company Profiles

4.3.1 UCB

4.3.2 Eisai

4.3.3 Pfizer

4.3.4 GlaxoSmithKline

4.3.5 Novartis

4.3.6 Abbott

4.3.7 Dainippon Sumitomo Pharma

5 Appendix

For more information visit http://www.researchandmarkets.com/research/q6mpk2/pharmapoint

Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]